L-alpha-Glycerophosphorylethanolamine

DB15872InvestigationalSmall molecule

L-alpha-Glycerophosphorylethanolamine is a medication indicated as an adjunct therapy in the maintenance of cognitive function in the elderly. A medication used along with other therapies to improve brain function in the elderly.

Formula / weight: C₅H₁₄NO₆P · 215.142 g/mol (avg)

Resolves to

Compound

UNIIO35QN01X8FCAS33049-08-0ChEBI143890KEGGC01233

Clinical / RWD

RxNorm1876508

Structure

InChIKeyJZNWSCPGTDBMEW-RXMQYKEDSA-NSMILESNCCOP(O)(=O)OC[C@H](O)CO

What you can answer from here — as of March 06, 2025

1Structured indicationCondition, population, route and combination as fields, not prose

1ContraindicationEach with its own population and attribute set

4Marketed productsAcross 1 country and 1 labeller

1+ReferenceStructured and connected to the statements they support

Which other approved drugs treat the same conditions as L-alpha-Glycerophosphorylethanolamine, and which companies have late-stage candidates in those indications?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account